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Introduction
At least 20% of women of reproductive age develop
clinically detectable uterine fibroids; however, if small,
clinically undetectable or microscopic fibroids are
included, the incidence is 70–75%. Uterine fibroids
are, therefore, the most common female pelvic tumor.
Fibroids comprise smooth muscle and extracellular
matrix (ECM). ECM is composed of collagen, proteo-
glycan, and fibronectin. Different tumors have differ-
ent ratios of smooth muscle to ECM, but fibroids have
the highest ratio of ECM. The etiology of fibroids is
unclear, but most originate from a single cell. Fibroids
generally present with no symptoms, and only 20–50%,
especially of the submucous type, have detectable
symptoms such as abnormal uterine bleeding (30%).
Other common symptoms include abdominal or pelvic
pressure, encompassing back pain, constipation, uri-
nary frequency or urinary retention, and infertility. The
indications for treatment of uterine fibroids include
metrorrhagia with anemia, pelvic pain or pelvic pres-
sure that interferes with daily life, ureteral compres-
sion, rapid tumor growth, tumor growth following
menopause, and infertility.
Management of Uterine Fibroids
Watchful waiting is the most common approach to
uterine fibroids, followed by medical treatment.
However, no long-lasting effects of medical treatment
have been reported, and surgery is, therefore, still con-
sidered to be the best means of treating symptomatic
fibroids. Surgical treatments include hysterectomy and
myomectomy. Myomectomy can be accomplished using
different approaches, including transabdominal (via
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laparotomy or laparoscopy) or transvaginal (with or
without hysteroscopy) approaches. This review focuses
on discussion of the laparoscopic approach.
Key Points of Laparoscopic Myomectomy
(LM)
The challenges associated with performing LM are
related to the approach angles of the instruments and
to uterine defect repair. Problems with the approach
angles of the instruments include placement of the tro-
cars; it is difficult to remove large fibroids using tradi-
tional trocar positionings because of the relatively
limited operating field. Laparoscopic repair of the
uterine defect requires not only highly skillful suturing
by the surgeon, but also proficient collaboration with
the surgical assistant. In addition, the removal of the
fibroids from the abdomen and the control of operative
blood loss also affect the success of the surgery.
Placement of Trocars
Correct trocar placement is an important factor dur-
ing surgery. Traditional portal sites are suitable for
medium-sized masses. Videolaparoscopy has been per-
formed using 5-mm or 10-mm principal trocars intro-
duced through the umbilicus. Two ancillary cannulas
are placed under laparoscopic visualization: one 5-
mm cannula in the right lower quadrant lateral to the
inferior epigastric arteries and one 5-mm cannula in
the left lower quadrant. For patients with uterine sizes
greater than 14 weeks’ gestation, the principal cannula
should be moved to the midpoint between the umbili-
cus and the xiphoid process (Lee-Huang point) [1].
Two puncture sites, both 5 mm, are made in the lower
abdomen at the paramedian line at the level of the
umbilicus. If more portal sites are needed, other can-
nulas can be introduced at the paramedian line, just
above the pubic hairline (Figure).
In our experience, the Lee-Huang point approach
seems to provide a safe location for primary trocar
placement in patients with previous pelvic surgery,
gynecologic malignancies, and large pelvic masses. A
median longitudinal incision through the linea alba
avoids major blood vessels and nerves and affords wide
access to the abdominal cavity. It provides a good visual
angle and increases the working distance in cases of
resection of large myomas. It also avoids intestinal
injury in the umbilical area after previous abdominal
surgeries. Lee-Huang point insertion may, therefore,
be the point of choice in LM for large fibroids [2–9].
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Figure. Abdominal port placements: Lee-Huang point and
additional portal sites.
LM Technique
Three major steps are involved in LM: (1) excision of
the myoma(s); (2) repair of the uterine defect; and (3)
extraction of the myoma specimen(s) [10].
The procedure is conducted with the patient in the
dorsal lithotomy and Trendelenburg position, with
both legs protected by elastic bandages. A Foley or
urethral catheter is inserted for constant urinary
drainage. A uterine manipulator is placed into the
uterus. Once a laparoscope and video camera are in
place, adhesions are lysed as necessary.
After identifying the location of all fibroids, a
transverse incision is made in the serosa overlying 
the largest tumor using a unipolar electrode. The inci-
sion is extended into the pseudocapsule down to 
the characteristically pearly white substance of the
tumor. Additional fibroids located at the same area
are removed through the same incision. However, for
nonadjacent fibroids, it is necessary to create a new
incision. A myoma screw or second puncture is then
inserted into the fibroid to apply traction, while a
probe (or any instrument that functions as a probe) 
is used to bluntly dissect in the cleavage plane to lever-
age the tumor against the uterine wall and pry it out 
of its bed. The unipolar electrode is used to further 
dissect pseudocapsule attachments. Vessels are elec-
trocoagulated using Kleppinger forceps before being 
cut. After fibroid removal, the uterine defect is irrigated.
Bleeding points are identified and controlled by 
electrocoagulation.
The uterine surgical defect is closed in layers. If
excessive myometrium and serosa are present, these
are trimmed off. A 0 monofilament poliglecaprone 25
(Monocryl; Ethicon Inc., Somerville, NJ) on a large
curved needle is used to make a deep and wide (1 cm
from the cut edge of the incision) bite. An original 90-
cm suture line is trimmed to 30 cm long to freely allow
continuous suturing inside the peritoneal cavity. The
needle enters the uterus through the serosa to the
myoma bed and emerges at the superficial level in a U
shape; the needle is then grasped and reapplied in a
reverse fashion. Intracorporeal knot tying is then used.
A continuous non-running lock suture with 1-cm incre-
ments is then applied, with each suture penetrating the
full thickness of the myometrium, following a method
similar to that applied during laparotomy.
After removal of all fibroids, the peritoneal cavity is
irrigated and until the lavage fluid is clear. A suction
drain (Jackson-Pratt drain) is introduced through a 
5-mm access site, if indicated. All port sites are sutured
using 3-0 polyglycolic acid sutures at the level of the fas-
cia to prevent herniation. The skin is approximated using
sterile adhesive tape.
Extraction of Fibroids
The extraction of the excised myomas from the abdomen
is one of the major concerns in LM. Transabdominal or
transvaginal extraction routes can be used. Removing
specimens via the vaginal approach (culdotomy) has
advantages in laparoscopic procedures, even though
there are risks of infection and bowel and ureteral
injuries [11]. Additional instruments need to be pre-
pared for vaginal surgery, and the surgical team mem-
bers have to change positions, making it a relatively
troublesome and time-consuming procedure. Never-
theless, portal extension combined with myoma slicing
could be useful for removing the specimens [12], even
though the 2- to 4-cm extension is associated with
higher postoperative pain and thus reduces its practi-
cal use.
Tumors can be easily removed through a culdotomy
opening, because the vaginal elasticity enables the pas-
sage of masses that are at least twice the size of the
incision. However, if a vaginal procedure cannot be
performed, e.g. because of an absence of sexual his-
tory, a narrow vagina, an obliterated cul-de-sac or large
myoma size, then culdotomy could become extremely
difficult.
The electric morcellator was first introduced for
laparoscopic use in 1993 [13]. Since then, it has been
used to remove various types of specimens [14–16].
Uterine myomas were identified by ultrasound during
LM in 78 nulliparous women, and we compared their
removal through culdotomy or by use of a power mor-
cellator [17]. The median removal time in the culdo-
tomy group (20 minutes) was significantly longer than
that in morcellator group (15 minutes; p = 0.007).
There were no significant differences in tumor size, total
specimen weight, patient body weight, total operating
time, blood loss, or postoperative stay between the
groups. Uterine myomas can thus be removed success-
fully through either port site in nullipara; however,
because of the reduced removal time, use of a power
morcellator is preferred.
Myomas can be removed using a power morcella-
tor through a 15-mm port site. The high-speed electri-
cal device is more effective than either a manual one 
or any sharp scissors or knife. The entire surgical pro-
cedure is accomplished abdominally, and the surgical
wounds are, therefore, clean, meaning that subsequent
antibiotic usage can be reduced. However, laparoscopic
morcellator-related injuries have been reported, of which
bowel injury is the most commonly reported during
myomectomy [18]. A surgeon’s experience determines
the degree of complications [19], and proper princi-
ples for handling the devices should be followed; the
moving blade should always remain anteriorly while
maintaining an adequate panoramic view, and visuali-
zation of the blade is necessary at all times.
Controlling Operative Blood Loss
LM, even though feasible, is considered to be a bloody
procedure, especially in the case of large fibroids. The
control of operative blood loss is, therefore, crucial,
especially in large intramural fibroids. Pretreatment with
a gonadotropin-releasing hormone agonist, myometrial
infiltration with vasopressin, and uterine artery ligation
before myomectomy have been reported to effectively
decrease the operative blood loss and blood transfusion
rate [20–22]. However, these measures are associated
with either increased expense or requiring extra steps to
be performed before the actual procedure.
We proposed a simplified method to control opera-
tive bleeding that does not require extra time. Two
ampoules of oxytocin (10 IU/mL/ampoule) were added
to saline solution (1,000 mL), which was run at a rate of
40 mIU/min during the course of LM [23]. Oxytocin acts
directly on the myometrium via its receptors on the uter-
ine smooth muscle cells, stimulating the contraction of
the uterus and reducing uterine perfusion. However, the
efficacy of oxytocin in stimulating the contraction of
smooth muscles in the nonpregnant uterus is much
lower than that of vasopressin [24]. After the application
of oxytocin, blood loss decreased significantly in the
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study group compared with the control group, but the
blood loss (269.5±225.8 mL) was still high when com-
pared with published data [25–27]. Although adverse
reactions, such as hypotension, arrhythmias or hypona-
tremia, can occur after systemic administration of oxy-
tocin, its margin of safety is greater than that for
vasopressin, and its convenient administration route
(intravenous instead of direct myometrial infiltration)
have made oxytocin our preferred choice of medication
in LM.
Although preoperative use of a gonadotropin-releasing
hormone agonist, temporary or permanent hemostasis
of the uterus, and the use of uterine myometrial contrac-
tion agents during myomectomy have been reported to
decrease operative blood loss and blood transfusion
rates [25,28], skilled surgical technique remains the
most important factor in reducing intraoperative
blood loss.
Types of LM
Three different LM approaches can be used: (1) laparo-
scopic-assisted abdominal myomectomy (LAAM); (2)
laparoscopic-assisted vaginal myomectomy (LAVM);
and (3) total LM (TLM).
Laparoscopic-assisted abdominal myomectomy
Nezhat et al [12] advocated this method in 1994.
Laparoscopic isolation of the largest fibroid is per-
formed, followed by minilaparotomy. This technique
allows simultaneous enucleation and removal of
fibroids from the abdomen and conventional multi-
layer suturing. The rationale behind this technique is
the belief that laparoscopy is unable to achieve the
same approximation of the suturing site as laparo-
tomy; therefore, hematomas might develop owing to
the poor approximation and hemostasis of the wound
site. In addition, the general use of electrocauteriza-
tion for hemostasis in laparoscopy could damage the
uterine tissues. LAAM can thus provide multilayer
suturing, reduce technical complexity, save valuable
operative time, and achieve a similar recovery period,
compared with pure LM.
Laparoscopic-assisted vaginal myomectomy
After laparoscopic identification of the location of all
fibroids, a guide suture is placed in the largest tumor for
identification. A grasper is used to pull the guide suture
into the vagina through the culdotomy incision.
Enucleation and removal of the fibroid, repair of the
uterine defect and hemostasis are performed vaginally
using conventional instruments [29–31].
The advantages of LAVM are similar to those of
LAAM. However, LAAM is mainly used to manage ante-
rior and fundal fibroids, while LAVM is better suited for
posterior and fundal masses. Vaginal capacity deter-
mines the difficulty of this procedure. LAVM is con-
traindicated in nulliparous women or those with a
narrow pelvis.
Total LM
To date, the only indications for TLM are peduncu-
lated and subserosal lesions [32]. Laparoscopic man-
agement of large or deep intramural lesions remains
controversial. According to our study [10], the mean
operation time for TLM for normal-sized fibroids
(diameter, < 7 cm) was 79.1 ± 28.6 minutes, and the
operative blood loss was 123.0 ± 89.7 mL. The opera-
tion time and blood loss both increased significantly
in the case of large intramural lesions (121.5 ± 58.9
minutes, and 346.3 ± 299.6 mL, respectively). The rate
of blood transfusion was also significantly higher in
the group with large fibroids (22.1% vs. 3.2%;
p < 0.001). However, there were no differences in the
length of hospital stay or overall incidence of operative
complications associated with the tumor size.
Repair of the uterine defect is a relatively difficult
task during TLM, and is considered the most crucial
stage. A skillful laparoscopic suturing technique is
indispensable for the close reapproximation of the
uterine defect. However, this procedure depends not
only on the highly skilled suturing technique of the sur-
geon, but also on the proficient collaboration of the
surgical assistant. Hence, TLM is still considered to be
a relatively difficult laparoscopic procedure.
To overcome this issue, we proposed a modified
laparoscopic suturing technique involving controlling
the tail of the suture with the surgeon’s hand while
sewing laparoscopically [33]. This technique can
achieve a good approximation of the uterine defect
and is an acceptable alternative that allows laparo-
scopic surgeons to perform the surgery assisted by an
assistant under training. However, for the skilled
laparoscopist or one teamed with an experienced
assistant, this modified suturing technique would be
of little value for the repair of uterine defects, because
the technique can result in leakage of air and an extra
long suture line pulling in and out of the peritoneum.
Outcome
Careful attention should be paid to the postoperative
integrity of the uterus. Ultrasound imaging and Doppler
velocimetry can be used to assess the uterine scar after
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LM [34,35]. On postoperative day 30, uterine scars
were reduced by 44.1–71.7%. Uterine rupture during
pregnancy, however, remains a considerable concern
after LM. All the published cases report rupture before
the start of labor (Table) [36–46]. Uterine rupture can
occur irrespective of the type of removed fibroid (intra-
mural or subserosal), the number of fibroids removed
(single or multiple), and the postoperative interval
(short-term or long-term). It is, therefore, difficult to
draw any definite conclusions from these cases.
Four methods can be used to assess fibroid recur-
rence after LM: (1) clinical signs or symptoms, (2) ultra-
sound investigation, (3) clinical examination with
oriented ultrasound investigation, or (4) self-reported
diagnosis based on questionnaires. Regular ultrasound
investigations result in the highest reported recurrence
rates. Nezhat et al [47] reported a cumulative risk of
recurrence of 10.6% after 1 year, 31.7% after 3 years, and
51.4% after 5 years. Rossetti et al [48] reported a crude
rate of recurrence of 27%, and most recurrences were
detected by sonography between 10 and 30 months
postoperatively. If these results are reliable, then women
with symptomatic uterine fibroids undergoing LM
should be advised of the high rate of recurrence.
Contraindications for LM
The surgical techniques involved in LM present a chal-
lenge to gynecologists. Location, size and number of
fibroids should be taken into consideration when
choosing patients as surgical candidates. The following
conditions should be regarded as relative contraindica-
tions for LM: (1) diffuse leiomyomata; (2) existence of
more than three fibroids > 7 cm; (3) uterine size greater
than 20 weeks’ gestation; (4) one fibroid >15 cm; (5)
women who have completed childbearing and who
desire hysterectomy; and (6) any medical condition that
is not suitable for anesthesia or prolonged laparoscopic
surgery.
Conclusion
LM was first described by Semm [49] in 1979. Since
then, many reports of this technique have been pub-
lished worldwide. The indications for LM have increased
in line with the improvements in laparoscopic techniques
and instruments that have taken place during the last
decade. This technique offers several benefits to
patients, but remains a challenging technical procedure
potentially associated with high surgical morbidity and
incidence of blood transfusion. Surgical strategies are
needed to overcome these problems associated with LM.
Since the surgery presents a challenging task for gynecol-
ogists, appropriate management strategies need to be
selected for each patient, and careful discussion and
counseling regarding all the issues are necessary.
Although LM is minimally invasive in terms of the
wound, it remains an advanced and invasive procedure.
It is important that surgeons should be aware of their
own abilities and the limitations of laparoscopy, and
should take care in patient selection.
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